53 related articles for article (PubMed ID: 10985927)
1. The metabolism of BW2258U89, a GRP receptor antagonist.
Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
[TBL] [Abstract][Full Text] [Related]
2. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
[TBL] [Abstract][Full Text] [Related]
3. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
[TBL] [Abstract][Full Text] [Related]
4. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
Moody TW; Staley J; Zia F; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
[TBL] [Abstract][Full Text] [Related]
5. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
[TBL] [Abstract][Full Text] [Related]
6. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells.
Draoui M; Chung P; Park M; Birrer M; Jakowlew S; Moody TW
Peptides; 1995; 16(2):289-92. PubMed ID: 7784258
[TBL] [Abstract][Full Text] [Related]
7. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
Moody TW; Leyton J; Garcia-Marin L; Jensen RT
Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
[TBL] [Abstract][Full Text] [Related]
8. CI-988 inhibits growth of small cell lung cancer cells.
Moody TW; Jensen RT
J Pharmacol Exp Ther; 2001 Dec; 299(3):1154-60. PubMed ID: 11714907
[TBL] [Abstract][Full Text] [Related]
9. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
[TBL] [Abstract][Full Text] [Related]
10. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
[TBL] [Abstract][Full Text] [Related]
11. (Tyr(0),Bpa(4))bombesin is a GRP receptor agonist.
Casibang M; Moody TW
Peptides; 2000 May; 21(5):649-53. PubMed ID: 10876047
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo metabolism of Lu-AMBA, a GRP-receptor binding compound, and the synthesis and characterization of its metabolites.
Linder KE; Metcalfe E; Arunachalam T; Chen J; Eaton SM; Feng W; Fan H; Raju N; Cagnolini A; Lantry LE; Nunn AD; Swenson RE
Bioconjug Chem; 2009 Jun; 20(6):1171-8. PubMed ID: 19480415
[TBL] [Abstract][Full Text] [Related]
13. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
[TBL] [Abstract][Full Text] [Related]
14. The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29.
Washington MC; Mhalhal TR; Sayegh AI
Horm Behav; 2016 Sep; 85():1-4. PubMed ID: 27381650
[TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
16. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
17. CAI inhibits the growth of small cell lung cancer cells.
Moody TW; Chiles J; Moody E; Sieczkiewicz GJ; Kohn EC
Lung Cancer; 2003 Mar; 39(3):279-88. PubMed ID: 12609566
[TBL] [Abstract][Full Text] [Related]
18. Role of gastrin-releasing peptide and neuromedin B in anxiety and fear-related behavior.
Bédard T; Mountney C; Kent P; Anisman H; Merali Z
Behav Brain Res; 2007 Apr; 179(1):133-40. PubMed ID: 17335915
[TBL] [Abstract][Full Text] [Related]
19. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
[TBL] [Abstract][Full Text] [Related]
20. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
